IL10 and meningioma: Earlier investigations have demonstrated that increased IL-10 within the tumor microenvironment, including meningiomas, is associated with a poorer prognosis (Singh et al., 2019; Manjunath et al., 2022), highlighting the crucial role of inflammatory factor regulation in the pathophysiology of meningioma.